Clinical Trials Insight: 700029392
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 31 Jul 2008
At a glance
- Drugs Laninamivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors Biota Holdings
- 31 Jul 2008 Biota Holdings reported that dosing of CS 8958 was completed.
- 31 Jul 2008 Status changed from unconfirmed to in progress, based on a Biota Holdings media release.
- 20 Dec 2007 New trial record.